Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) arrhythmia
therapy. Furthermore, we discuss various promising cellular and mitochondrial
targetsImportance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal
Therapy of NF-kappa B Inhibitor DHMEQ
WANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) that
targeting amino acid metabolism such as methionine deprivation/IL1RN related gene
therapy may offer novel
and for
targeted therapy of age-associated pathologies, including malignant neoplasms. In this regard, the study